Nafarelin
- Generic Name
- Nafarelin
- Brand Names
- Synarel
- Drug Type
- Small Molecule
- Chemical Formula
- C66H83N17O13
- CAS Number
- 76932-56-4
- Unique Ingredient Identifier
- 1X0094V6JV
Overview
Nafarelin is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis.
Background
Nafarelin is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis.
Indication
用于子宫内膜异位症、不育症等。
Associated Conditions
- Central Precocious Puberty (CPP)
- Endometriosis
Clinical Trials
FDA Approved Products
Synarel
Manufacturer:Pfizer Laboratories Div Pfizer Inc
Route:NASAL
Strength:2 mg in 1 mL
Approved: 2023/02/08
NDC:0025-0166
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath